Search results for "Highlights"
GLP-1 receptor agonists may affect colonoscopy bowel prep
A retrospective cohort study found that patients taking glucagon-like peptide-1 (GLP-1) receptor agonists for diabetes or obesity had lower-quality bowel prep for colonoscopy and were more likely to be called back for a repeat test.
https://gastroenterology.acponline.org/archives/2023/10/27/3.htm
27 Oct 2023
Lactated Ringer's associated with better outcomes from acute pancreatitis
Patients who received only lactated Ringer's during their first 24 hours of hospitalization had about half the odds of moderately severe or severe pancreatitis as those who received only normal saline, according to a prospective international study.
https://gastroenterology.acponline.org/archives/2023/07/28/2.htm
28 Jul 2023
IBD increases long-term stroke risk, study finds
A Swedish study found that patients with inflammatory bowel disease (IBD) were at higher risk for incident stroke, especially ischemic stroke, versus matched controls and versus their siblings for up to 25 years.
https://gastroenterology.acponline.org/archives/2023/06/23/3.htm
23 Jun 2023
PPIs, H2 blockers not linked to cognitive problems in older patients, study finds
Data from a post hoc analysis of a randomized trial should provide reassurance about the safety of long-term use of proton-pump inhibitors (PPIs) among adults ages 65 years and older, according to the authors.
https://gastroenterology.acponline.org/archives/2023/06/23/2.htm
23 Jun 2023
Mesalamine moderately useful in IBS, but confidence in evidence is low
The authors of a recent meta-analysis wrote that guidelines for irritable bowel syndrome (IBS) management should not recommend the drug until adequately powered studies are available.
https://gastroenterology.acponline.org/archives/2023/03/24/3.htm
24 Mar 2023
Less frequent dosing of bismuth quadruple therapy appears effective for H. pylori therapy
A study of Spanish patients found that single-capsule bismuth quadruple therapy administered three times a day was more effective for treating Helicobacter pylori than four times a day, with no differences in adherence or safety.
https://gastroenterology.acponline.org/archives/2023/07/28/3.htm
28 Jul 2023
Phase 3 study offers evidence on drug dosing for eosinophilic esophagitis
Findings from an industry-funded study showed that using dupilumab weekly, rather than every two weeks, improved symptoms in adults and adolescents with eosinophilic esophagitis.
https://gastroenterology.acponline.org/archives/2023/09/22/2.htm
22 Sep 2023
ACG updates its guideline on acute lower GI bleeding
The American College of Gastroenterology (ACG) now recommends risk stratification to identify patients who can be discharged early and advises on the use of anticoagulant reversal agents, among other changes.
https://gastroenterology.acponline.org/archives/2023/03/24/2.htm
24 Mar 2023
RYGB associated with more alcohol-related hospitalizations than other weight-loss strategies
A recent cohort study compared hospitalizations related to alcohol use disorder and mortality among veterans who received Roux-en-Y gastric bypass (RYGB) surgery, sleeve gastrectomy, or referral to a weight management program.
https://gastroenterology.acponline.org/archives/2022/12/23/3.htm
23 Dec 2022
Fenofibrate may augment treatment for primary biliary cholangitis
Adding fenofibrate to ursodeoxycholic acid significantly increased the likelihood of biochemical response and normalization of alkaline phosphatase levels, a small trial in China found.
https://gastroenterology.acponline.org/archives/2023/11/17/3.htm
17 Nov 2023